Order Article Reprints

Hamada Y, Tanoue K, Arigami T, Yamakuchi M, Okawa M, Matsushita D, Takenouchi K, Yamada S, Maywar DN, Nakayama C, et al. The Vascular Endothelial Growth Factor-A121/Vascular Endothelial Growth Factor-A165 Ratio as a Predictor of the Therapeutic Response to Immune Checkpoint Inhibitors in Gastric Cancer. Cancers. 2024; 16(23):3958. https://doi.org/10.3390/cancers16233958

Hamada, Yuki, Kiyonori Tanoue, Takaaki Arigami, Munekazu Yamakuchi, Masashi Okawa, Daisuke Matsushita, Kazunori Takenouchi, Shingo Yamada, Drew N. Maywar, Chieri Nakayama, and et al. 2024. "The Vascular Endothelial Growth Factor-A121/Vascular Endothelial Growth Factor-A165 Ratio as a Predictor of the Therapeutic Response to Immune Checkpoint Inhibitors in Gastric Cancer" Cancers 16, no. 23: 3958. https://doi.org/10.3390/cancers16233958

Hamada, Y., Tanoue, K., Arigami, T., Yamakuchi, M., Okawa, M., Matsushita, D., Takenouchi, K., Yamada, S., Maywar, D. N., Nakayama, C., Oyama, Y., Higashi, S., Fujisaki, C., Hozaka, Y., Kita, Y., Hashiguchi, T., & Ohtsuka, T. (2024). The Vascular Endothelial Growth Factor-A121/Vascular Endothelial Growth Factor-A165 Ratio as a Predictor of the Therapeutic Response to Immune Checkpoint Inhibitors in Gastric Cancer. Cancers, 16(23), 3958. https://doi.org/10.3390/cancers16233958